In a HuffPost story written by a reporter whose father donated his body to OHSU, Tamara Ostervoss says: “Whole-body donation far surpasses the initial gift. Learners take this knowledge gained and apply it to all patients that they treat for the rest of their career. Anyone who has sought health care has benefited from this gift, whether they know it or not.”

OHSU’s Casey Eye Institute and the Foundation Fighting Blindness will co-host their annual Retinal Cell and Gene Therapy Innovation Summit April 21 in New Orleans to discuss the latest research and potential treatments for inherited retinal disease.

David Spencer, M.D., and Kim Burchiel, M.D., treated one of the patients whose initial results as a participants in a Phase 1/2 clinical trial have been released. The results indicate interneuron cell therapy substantially reduced seizure frequency for two patients with severe, drug-resistant focal epilepsy.

A story about state legislation that would provide medical debt protections for patients notes Oregon House of Representative officials said OHSU was the only Oregon hospital that has consistently provided charity care since a 2019 law was enacted to require non-profit hospitals to provide financial assistance to both insured and uninsured patients who can’t afford their medical bills.

At an April 19 OHSU Board of Directors meeting, Lawrence Furnstahl reported OHSU was operating with a 2.4% profit margin as of March 31 even though the university had planned for a break-even budget during the current fiscal year. The board also extended the contract of President Danny Jacobs, M.D., M.P.H., FACS, through July 2026 by a 6-2 vote.

In a story about former professional athletes struggling with health issues related to their athletic careers turning to psychedelics despite limited evidence supporting their use, Atheir Abbas, M.D., Ph.D., says: “When people are upset and we’re not meeting their needs, they’re going to try things out. Hopefully, scientists can catch up to understanding why people think this is really helpful. And maybe it is helpful, but let’s try to figure out if it is and how."

La OHSU se asocia con la OHA y la gobernadora de Oregón, Tina Kotek, para comprar un suministro de tres años del medicamento abortivo mifepristona mientras continúan las batallas legales sobre la aprobación del medicamento por parte de la FDA hace más de 20 años.

Alison Edelman, M.D., M.P.H., shares her reaction to the U.S. Supreme Court’s decision to maintain broad access to mifepristone, the most commonly used medication to end early pregnancy.

OHSU President Danny Jacobs, M.D., M.P.H., FACS, will speak at the May 25 State of Black Affairs summit, which Oregon State University holds annually to empower Black professionals, students and families.

At an April 19 OHSU Board of Directors meeting, Lawrence Furnstahl reported OHSU was operating with a 2.4% profit margin as of March 31 even though the university had planned for a break-even budget during the current fiscal year. The board also extended the contract of President Danny Jacobs, M.D., M.P.H., FACS, through July 2026 by a 6-2 vote.